Login to Your Account

BARDA Gives Biotech Firms $39.6M for Radiation Drugs

By Marie Powers

Friday, September 30, 2011
Three biotechs and a U.S. university will share $39.6 million in new funding from the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to progress drugs designed to treat injuries associated with acute radiation syndrome (ARS).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription